Pioglitazone Hydrochloride
13 NDCs across 3 manufacturers|13 Generic,0 Brand
Pioglitazone Hydrochloride is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jul 15, 1999, and the first generic was approved Aug 17, 2012. FDA's Orange Book lists 36 AB-rated (therapeutically equivalent) products for this ingredient.
Pioglitazone Hydrochloride is available as 13 NDCs from 3 manufacturers (13 generic, 0 brand), with NADAC prices from $0.07 to $0.11 per EA — a 70% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
13
13G / 0B
Manufacturers
3
competing in market
Price Spread
$0.07 – $0.11
per EA
7d Activity
avg +3.5% WoW · of 13 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Aurobindo Pharma Limited manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Peroxisome Proliferator Receptor alpha Agonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing PIOGLITAZONE HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PIOGLITAZONE HCL 45 MG TABLET | $0.1145 per EA | +3.00% |
PIOGLITAZONE HCL 45 MG TABLET | $0.1145 per EA | +3.00% |
PIOGLITAZONE HCL 45 MG TABLET | $0.1145 per EA | +3.00% |
PIOGLITAZONE HCL 45 MG TABLET | $0.1145 per EA | +3.00% |
PIOGLITAZONE HCL 30 MG TABLET | $0.0930 per EA | +2.98% |
PIOGLITAZONE HCL 30 MG TABLET | $0.0930 per EA | +2.98% |
PIOGLITAZONE HCL 30 MG TABLET | $0.0930 per EA | +2.98% |
PIOGLITAZONE HCL 30 MG TABLET | $0.0930 per EA | +2.98% |
PIOGLITAZONE HCL 15 MG TABLET | $0.0675 per EA | +4.31% |
PIOGLITAZONE HCL 15 MG TABLET | $0.0675 per EA | +4.31% |
PIOGLITAZONE HCL 15 MG TABLET | $0.0675 per EA | +4.31% |
PIOGLITAZONE HCL 15 MG TABLET | $0.0675 per EA | +4.31% |
PIOGLITAZONE HCL 15 MG TABLET | $0.0675 per EA | +4.31% |
Frequently Asked Questions
What is Pioglitazone Hydrochloride used to treat?
Pioglitazone Hydrochloride is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
When did Pioglitazone Hydrochloride become available as a generic?
FDA approved the first generic Pioglitazone Hydrochloride (ANDA) on Aug 17, 2012. The Orange Book currently lists 36 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Pioglitazone Hydrochloride products are on the market?
The Pioglitazone Hydrochloride drug market contains 13 NDCs from 3 manufacturers — 13 generic and 0 brand products.
What is the price range for Pioglitazone Hydrochloride?
NADAC reference prices for Pioglitazone Hydrochloride range from $0.0675 to $0.1145 per EA — a 70% difference between cheapest and most expensive.
Which manufacturers make Pioglitazone Hydrochloride?
3 manufacturers list Pioglitazone Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Aurobindo Pharma Limited (7), Chartwell RX LLC (3), Quallent Pharmaceuticals Health LLC (3).
How has the price of Pioglitazone Hydrochloride changed recently?
Over the past 7 days, 39 Pioglitazone Hydrochloride NDCs rose and 0 fell, with a market-wide average change of +3.5%.